Soligenix Announces SGX945 Receives Promising Innovative Medicine Designation from the UK Medicines and Healthcare Products Regulatory Agency
Go back to Soligenix Announces SGX945 Receives Promising Innovative Medicine Designation from the UK Medicines and Healthcare Products Regulatory Agency| Soligenix, Inc. (NASDAQ: SNGX) | Delayed: 0.38 -0.01 (2.56%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.39 | 52 Week High | $4.35 | |||
| Open | $0.39 | 52 Week Low | $0.44 | |||
| Day High | $0.40 | P/E | N/A | |||
| Day Low | $0.38 | EPS | $-0.81 | |||
| Volume | 516,739 | |||||

